Mesabi Trust (MSB) stock analysis
Close on Nov 11, 2026Market cap $225.93MP/E 35.1Yield –
StockData Score
Prices as of Nov 11, 2026How the score works
Weak8 of 30 checks passed
Mesabi Trust passes 8 of the 30 checks behind our score; 9 could not be run for lack of data and count as not passed. Each dot in the shape is one check — hover it for the numbers.
- Valuation
- 0/6
- Growth
- 1/6
- Past performance
- 1/6
- Financial health
- 5/6
- Dividend
- 1/6
What stands out
No debt
Mesabi Trust has no borrowings on its latest balance sheet.
Revenue growing 10%+ a year
Revenue grew 31.3% a year over the last three fiscal years.
Interest well covered
No meaningful interest expense to cover.
Debt covered by cash flow
There is no debt to cover.
What to watch
Margin of safety under 20%
The price is 1.8% above fair value, so there is no margin of safety.
Trading above fair value
The share price of $17.22 is above our fair value estimate of $16.92.
Earnings shrank over 5 years
Net income shrank 9.9% a year on average over the last five fiscal years.
Earnings growth not accelerating
Net income grew -93.0% over the last twelve months, against a 5-year average of -9.9% a year.
Valuation0/6
P/E above its 5-year median
Mesabi Trust's P/E of 35.1 is above its own 5-year median of 10.6.
P/E above the industry
Mesabi Trust's P/E of 35.1 is above the Miscellaneous Investing median of 26.3.
EV/EBITDA against its history
Needs positive EBITDA and price history.
P/S above the industry
Mesabi Trust's price-to-sales of 18.97 is above the Miscellaneous Investing median of 4.14 (book value is negative, so we use sales).
Trading above fair value
The share price of $17.22 is above our fair value estimate of $16.92.
Margin of safety under 20%
The price is 1.8% above fair value, so there is no margin of safety.
Growth1/6
Revenue growing 10%+ a year
Revenue grew 31.3% a year over the last three fiscal years.
EPS growth over 3 years
Needs positive EPS three years ago and today.
Earnings growth not accelerating
Net income grew -93.0% over the last twelve months, against a 5-year average of -9.9% a year.
Growing slower than the industry
Revenue grew -87.6% over the last twelve months; the Miscellaneous Investing median is 4.6%.
Company guidance
No outlook found in earnings releases from the last twelve months.
Gross margin slipping
Gross margin was 54.5% over the last twelve months, against 96.4% a year earlier.
Past performance1/6
Return on equity
Needs positive equity and five years of results.
Return on invested capital
Needs operating income and invested capital.
Return on equity against the industry
Needs positive equity.
Earnings shrank over 5 years
Net income shrank 9.9% a year on average over the last five fiscal years.
Net margin below its 5-year average
Net margin was 54.5% over the last twelve months, against a 5-year average of 84.3%.
Net margin above the industry
Mesabi Trust's net margin of 54.5% is above the Miscellaneous Investing median of 10.3%.
Financial health5/6
No debt
Mesabi Trust has no borrowings on its latest balance sheet.
Debt not rising
With no debt today, leverage cannot have risen.
Debt covered by cash flow
There is no debt to cover.
Interest well covered
No meaningful interest expense to cover.
Short-term liquidity
The balance sheet is not split into current and non-current items.
Low bankruptcy risk
The Altman Z-score is 60.78; above 3 is the safe zone and below 1.8 the distress zone.
Dividend1/6
Pays a dividend
Mesabi Trust paid dividends worth 3.2% of the share price over the last twelve months.
Yield below Treasuries
The 3.2% yield is below the 4.4% on a 1-year Treasury.
Yield below the top quarter
The top quarter of US dividend payers yield 3.8% or more; Mesabi Trust yields 3.2%.
Dividend stability
Fewer than five years of dividend history.
Not covered by earnings
Dividends take 194% of net income, leaving little room.
Cash-flow cover
Needs dividends paid and free cash flow.
Fair value
How we estimate itOur estimate per share
$16.92
The share price is 2% above this estimate.
| Method | Multiple used | Own 5Y median | Industry median | Value per share | Weight |
|---|---|---|---|---|---|
| P/E | 18.8× | 10.6× | 26.3× | $9.22 | 73% |
| Earnings power | 8.3% cost of equity | – | – | $37.45 | 27% |
| Fair value | $16.92 | 100% | |||
Valuation over time
Using the earnings and balance sheet published at each date, not today's.
- P/E at month end
- Own 5-year median 10.6
- Miscellaneous Investing median 26.3
An estimate from reported numbers and market multiples, not a price target or investment advice. It can be far off for companies whose profits are about to change sharply.
Market risk
From the past year of daily prices.
Liquidity
High risk
- Average value traded per day
- $868.15K
- Value traded per 1% price move
- $367.23K
Downside
Medium risk
- Typical loss in a bad month
- 19.9%
- Volatility (annualized)
- 45%
- Sharpe ratio, 1 year
- -1.21
- Beta to the S&P 500 (5Y)
- 0.69
Typical bad-month loss, week by week
Margins
Share of revenue, fiscal years 2011 to 2025
Gross margin
Net margin
Growth rates
Compound annual growth to fiscal 2025
| Per year | 1 year | 3 years | 5 years | 10 years | Five-year pace |
|---|---|---|---|---|---|
| Revenue | -82.2% | +31.3% | -7.6% | +6.1% | |
| Gross profit | -85.1% | +37.7% | -9.9% | – | |
| Net income | -85.1% | +37.7% | -9.9% | +4.9% |
Returns and balance sheet
10 fiscal years. Hover a measure to see how it is calculated.
| Measure | FY2016 | FY2020 | FY2025 | Trend |
|---|---|---|---|---|
| Return on assets | 81.1% | 100.5% | 22.0% | |
| Diluted shares | 13M | 13M | 13M |
Cash use needs five years of cash flow figures
Mesabi Trust does not report operating cash flow and capital expenditure for each of the last five fiscal years.
DuPont needs revenue, assets and equity
This company does not report all three for consecutive years.
Piotroski F-Score
Nine tests of profitability, balance sheet and efficiency, fiscal 2025 against fiscal 2024
- ProfitableNet income above zero$13.87M
- Cash generatingOperating cash flow above zero$14.40M
- Return on assets improvedROA up on the prior year349.5% → 13.6%
- Earnings backed by cashOperating cash flow above net income$14.40M vs $13.87M
- Less leverageLong-term debt to assets fell– → –
- Better liquidityCurrent ratio rose– → –
- No dilutionShare count did not rise13M → 13M
- Gross margin improvedGross margin up on the prior year94.60% → 79.14%
- More efficientAsset turnover rose3.69 → 0.17
See a number that looks wrong?